当前位置:首页 - 行情中心 - 国药一致(000028) - 财务分析

国药一致

(000028)

  

流通市值:165.93亿  总市值:193.18亿
流通股本:4.78亿   总股本:5.57亿

国药一致(000028)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润4.46亿元,每股收益0.70元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益2141881.65万元,未分配利润1270029.18万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产5152499.73万元,负债3010618.08万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入19,090,480,767.975,477,484,620.3156,585,864,462.4338,387,531,548.02
营业总成本18,628,475,913.3173,277,097,009.1454,981,233,258.6437,247,256,783.78
营业利润544,001,136.482,467,425,159.541,822,923,220.31,295,113,233.31
利润总额550,249,302.132,473,226,544.951,820,452,853.951,291,654,341.53
净利润446,123,063.021,958,487,100.71,450,194,883.181,029,405,515.14
其他综合收益-56,309.63-9,845.92-9,845.92
综合收益总额446,123,063.021,958,543,410.331,450,185,037.261,029,395,669.22
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计40,058,309,136.1336,370,054,575.9839,698,248,883.7438,840,028,022.31
非流动资产合计11,466,688,128.8811,201,040,203.2811,038,685,690.5311,042,910,738.28
资产总计51,524,997,265.0147,571,094,779.2650,736,934,574.2749,882,938,760.59
流动负债合计27,722,116,311.224,338,224,160.2928,071,671,339.5427,585,168,250.62
非流动负债合计2,384,064,495.582,255,030,138.582,199,374,507.312,203,592,198.75
负债合计30,106,180,806.7826,593,254,298.8730,271,045,846.8529,788,760,449.37
归属于母公司股东权益合计17,803,579,439.1317,414,808,729.0616,972,948,050.2516,613,532,160.81
股东权益合计21,418,816,458.2320,977,840,480.3920,465,888,727.4220,094,178,311.22
负债和股东权益合计51,524,997,265.0147,571,094,779.2650,736,934,574.2749,882,938,760.59
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计16,415,190,745.3278,562,180,993.5153,825,819,839.4535,311,862,263.36
经营活动现金流出小计17,049,336,514.2275,625,042,313.8352,360,350,737.7233,825,586,262.43
经营活动产生的现金流量净额-634,145,768.92,937,138,679.681,465,469,101.731,486,276,000.93
投资活动现金流入小计24,842,270.95201,293,129.85164,474,228.8385,294,587.16
投资活动现金流出小计76,829,236.18336,727,862.16228,962,940.88157,899,817.84
投资活动产生的现金流量净额-51,986,965.23-135,434,732.31-64,488,712.05-72,605,230.68
筹资活动现金流入小计991,611,668.122,109,693,118.781,420,106,804.21715,518,573.15
筹资活动现金流出小计872,571,674.194,517,334,636.083,434,757,444.842,125,198,114.71
筹资活动产生的现金流量净额119,039,993.93-2,407,641,517.3-2,014,650,640.63-1,409,679,541.56
汇率变动对现金及现金等价物的影响2,810.99-941,395.6-943,922.9-956,595.89
现金及现金等价物净增加额-567,089,929.21393,121,034.47-614,614,173.853,034,632.8
期末现金及现金等价物余额5,268,204,527.145,835,294,456.354,827,559,248.035,445,208,054.68
最新报告期:2024-04-15
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
西南证券杜向阳3.183.493.932024-04-15
兴业证券孙媛媛3.123.403.712024-04-11
中信建投证券刘若飞,贺菊颖3.213.594.032024-04-08
华泰证券代雯,孔垂岩,王殷杰3.163.423.712024-04-08
中金公司张琎,朱言音3.193.55--2024-03-18
TOP↑